Madrigal Pharmaceuticals Statistics
Total Valuation
LON:0JXI has a market cap or net worth of GBP 4.48 billion. The enterprise value is 3.94 billion.
Market Cap | 4.48B |
Enterprise Value | 3.94B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 22.20M |
Shares Outstanding | n/a |
Shares Change (YoY) | +13.87% |
Shares Change (QoQ) | +0.74% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 12.18M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 18.22 |
PB Ratio | 8.14 |
P/TBV Ratio | 8.19 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -13.02 |
EV / Sales | 16.90 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -12.86 |
Financial Position
The company has a current ratio of 5.91, with a Debt / Equity ratio of 0.17.
Current Ratio | 5.91 |
Quick Ratio | 5.41 |
Debt / Equity | 0.17 |
Debt / EBITDA | n/a |
Debt / FCF | -0.30 |
Interest Coverage | -30.09 |
Financial Efficiency
Return on equity (ROE) is -50.16% and return on invested capital (ROIC) is -29.54%.
Return on Equity (ROE) | -50.16% |
Return on Assets (ROA) | -25.56% |
Return on Invested Capital (ROIC) | -29.54% |
Return on Capital Employed (ROCE) | -51.26% |
Revenue Per Employee | 465,249 |
Profits Per Employee | -574,026 |
Employee Count | 528 |
Asset Turnover | 0.31 |
Inventory Turnover | 0.38 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.58% in the last 52 weeks. The beta is -0.76, so LON:0JXI's price volatility has been lower than the market average.
Beta (5Y) | -0.76 |
52-Week Price Change | +14.58% |
50-Day Moving Average | 306.69 |
200-Day Moving Average | 292.81 |
Relative Strength Index (RSI) | 41.43 |
Average Volume (20 Days) | 83 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 11.70 |
Income Statement
In the last 12 months, LON:0JXI had revenue of GBP 245.65 million and -303.09 million in losses. Loss per share was -13.91.
Revenue | 245.65M |
Gross Profit | 237.33M |
Operating Income | -329.06M |
Pretax Income | -303.09M |
Net Income | -303.09M |
EBITDA | -328.05M |
EBIT | -329.06M |
Loss Per Share | -13.91 |
Balance Sheet
The company has 652.53 million in cash and 92.70 million in debt, giving a net cash position of 559.82 million.
Cash & Cash Equivalents | 652.53M |
Total Debt | 92.70M |
Net Cash | 559.82M |
Net Cash Per Share | n/a |
Equity (Book Value) | 550.03M |
Book Value Per Share | 24.79 |
Working Capital | 635.25M |
Cash Flow
In the last 12 months, operating cash flow was -305.96 million and capital expenditures -855,259, giving a free cash flow of -306.82 million.
Operating Cash Flow | -305.96M |
Capital Expenditures | -855,259 |
Free Cash Flow | -306.82M |
FCF Per Share | n/a |
Margins
Gross margin is 96.61%, with operating and profit margins of -133.95% and -123.38%.
Gross Margin | 96.61% |
Operating Margin | -133.95% |
Pretax Margin | -123.38% |
Profit Margin | -123.38% |
EBITDA Margin | -133.54% |
EBIT Margin | -133.95% |
FCF Margin | n/a |
Dividends & Yields
LON:0JXI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.87% |
Shareholder Yield | n/a |
Earnings Yield | -6.77% |
FCF Yield | -6.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LON:0JXI has an Altman Z-Score of 9.76.
Altman Z-Score | 9.76 |
Piotroski F-Score | n/a |